Article
[Comparison of clinical outcomes of patients with non-small cell lung cancer harboring different types of epidermal growth factor receptor sensitive mutations after first-line EGFR-TKI treatment].
Zhonghua zhong liu za zhi [Chinese journal of oncology] - 23 Mar 2016
Liu J J, Zhang S, Wu C J, Ma L X, Liu Y, Li H, Cui H X, Cheng Y
Abstract excerpt
OBJECTIVE: To analyze whether there are differences in the efficacy and clinical outcomes to first-line tyrosine kinase inhibitors (TKI) therapy in Chinese patients with metastatic non-small-cell lung cancer (NSCLC) harboring different subtypes of epidermal growth factor receptor (EGFR) mutations. METHODS: A retrospective analysis was made on the clinical data of stage ⅢB or Ⅳ NSCLC patients who were diagnosed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.